BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26166260)

  • 1. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management.
    Beleznay K; Carruthers JD; Carruthers A; Mummert ME; Humphrey S
    Dermatol Surg; 2015 Aug; 41(8):929-39. PubMed ID: 26166260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on delayed onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management.
    Del Campo R; Mandy S
    Dermatol Surg; 2015 Aug; 41(8):940-1. PubMed ID: 26177113
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients.
    Humphrey S; Jones DH; Carruthers JD; Carruthers A; Beleznay K; Wesley N; Black JM; Vanderveen S; Minokadeh A
    J Am Acad Dermatol; 2020 Jul; 83(1):86-95. PubMed ID: 32035107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-Onset Nodules to Differentially Crosslinked Hyaluronic Acids: Comparative Incidence and Risk Assessment.
    Sadeghpour M; Quatrano NA; Bonati LM; Arndt KA; Dover JS; Kaminer MS
    Dermatol Surg; 2019 Aug; 45(8):1085-1094. PubMed ID: 30789508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Experience With 11,460 mL of a 20-mg/mL, Smooth, Highly Cohesive, Viscous Hyaluronic Acid Filler.
    Humphrey S; Carruthers J; Carruthers A
    Dermatol Surg; 2015 Sep; 41(9):1060-7. PubMed ID: 26230330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant and Recurrent Late Reaction to Hyaluronic Acid-Based Gel.
    Artzi O; Loizides C; Verner I; Landau M
    Dermatol Surg; 2016 Jan; 42(1):31-7. PubMed ID: 26655699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Facial angioedema following hyaluronic acid injection].
    Stephan F; Maatouk I; Moutran R; Obeid G
    Ann Dermatol Venereol; 2012 Jan; 139(1):63-4. PubMed ID: 22225746
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel.
    Angus JE; Affleck AG; Leach IH; Millard LG
    Br J Dermatol; 2006 Nov; 155(5):1077-8. PubMed ID: 17034549
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed allergic hypersensitivity to hyaluronidase during the treatment of granulomatous hyaluronic acid reactions.
    Wu L; Liu X; Jian X; Wu X; Xu N; Dou X; Yu B
    J Cosmet Dermatol; 2018 Dec; 17(6):991-995. PubMed ID: 29159865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with hyaluronic acid-filler complications.
    Park TH; Seo SW; Kim JK; Chang CH
    J Plast Reconstr Aesthet Surg; 2011 Jul; 64(7):892-6. PubMed ID: 21310674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-Onset Sweet-like Dermatitis After Facial Hyaluronic Acid Filler Injection.
    Brys AK; Cox SE
    Dermatol Surg; 2020 Dec; 46(12):1759-1761. PubMed ID: 31652231
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial ischemia after hyaluronic acid injection.
    Banh K
    J Emerg Med; 2013 Jan; 44(1):169-70. PubMed ID: 21958454
    [No Abstract]   [Full Text] [Related]  

  • 14. Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler: What to Do After a Good Periocular Treatment Goes Bad.
    Skippen B; Baldelli I; Hartstein M; Casabona G; Montes JR; Bernardini F
    Aesthet Surg J; 2020 Jan; 40(2):197-205. PubMed ID: 30877762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and treatment of non-infectious hyaluronic acid reactions.
    Hatcher JL; Goldman ND
    J Dermatolog Treat; 2014 Dec; 25(6):513-5. PubMed ID: 22702401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and treatment of delayed-onset nodules after VYC filler injections to 2139 patients at a single Canadian clinic.
    Rivers JK
    J Cosmet Dermatol; 2022 Jun; 21(6):2379-2386. PubMed ID: 35451214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undesirable effects after treatment with dermal fillers.
    Rodrigues-Barata AR; Camacho-Martínez FM
    J Drugs Dermatol; 2013 Apr; 12(4):e59-62. PubMed ID: 23652907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation.
    Pérez-Pérez L; García-Gavín J; Wortsman X; Santos-Briz Á
    Dermatol Surg; 2017 Apr; 43(4):605-608. PubMed ID: 27748693
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous granulomatous reaction to injectable hyaluronic acid gel.
    Ghislanzoni M; Bianchi F; Barbareschi M; Alessi E
    Br J Dermatol; 2006 Apr; 154(4):755-8. PubMed ID: 16536824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler.
    Sidwell RU; Dhillon AP; Butler PE; Rustin MH
    Clin Exp Dermatol; 2004 Nov; 29(6):630-2. PubMed ID: 15550141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.